Meditation for people with amyotrophic lateral sclerosis and their caregivers

Completed

• Conditions: Amyotrophic lateral sclerosis (ALS); Nervous System Diseases

• Registration Number: ISRCTN88066803
• Lead Sponsor: iguarda Ca' Granda Hospital

Brief Summary

2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/28229508

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-12-11
• Study Completion: 2017-02-28
• Last Update Posted: 24 September 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Aged 18 years or over
2. Probable or definite ALS diagnosis within 6 months of recruitment
3. Ability to speak and comprehend
4. A caregiver identified as the person who provided the most of care and assistance (e.g. a close relative)

Exclusion Criteria

1. Co-morbidity
2. History of psychiatric illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life is assessed using the ALS-Specific Quality of Life Revised (ALSSQoL-r) at baseline, 3, 6 and 12 months.

Secondary Outcome Measures

Name	Time	Method
1. Anxiety and Depression measured using the Hospital Anxiety and Depression Scale at baseline, 3, 6, and 12 months<br>2. Mindfulness is measured using the Five Facet Mindfulness Questionnaire at baseline, 3, 6, and 12 months